---
figid: PMC7369697__ijms-21-04576-g001
figtitle: BRAF signaling pathway including abnormal signaling from BRAFV600E mutated
  proteins
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC7369697
filename: ijms-21-04576-g001.jpg
figlink: pmc/articles/PMC7369697/figure/ijms-21-04576-f001/
number: F1
caption: BRAF signaling pathway including abnormal signaling from BRAFV600E mutated
  proteins. The scheme also shows inhibitors and their targets—drugs approved in melanoma
  treatment are bolded, we also show other potential inhibitors (drugs in development
  or registered in other indications). RTK–receptor tyrosine kinase; RTKs–receptor
  tyrosine kinases; BRAF–proto-oncogene B-Raf; BRAFi–BRAF inhibitors; ARAF–serine/threonine-protein
  kinase A-Raf; CRAF–RAF proto-oncogene serine/threonine-protein kinase, also known
  as proto-oncogene c-RAF; PI3K–phosphoinositide 3-kinases; P–phosphoprotein; MEK–mitogen-activated
  protein kinase kinase; ERK–extracellular-signal-regulated kinase; COT–mitogen-activated
  protein kinase kinase kinase 8 or serine/threonine-protein kinase cot-1; MCL-1–induced
  myeloid leukemia cell differentiation protein Mcl-1; AKT–protein kinase B, also
  known as Akt; Rb–the retinoblastoma protein; Bad–BCL2 associated agonist of cell
  death; c-Myc–Myc proto-oncogene protein; c-Jun–Jun-related antigen, isoform C; Ets–ETS
  transcription factor family; c-Fos–proto-oncogene c-Fos.
papertitle: Targeted Therapy in Melanoma and Mechanisms of Resistance.
reftext: Anna M. Czarnecka, et al. Int J Mol Sci. 2020 Jul;21(13):4576.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.96442
figid_alias: PMC7369697__F1
figtype: Figure
redirect_from: /figures/PMC7369697__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7369697__ijms-21-04576-g001.html
  '@type': Dataset
  description: BRAF signaling pathway including abnormal signaling from BRAFV600E
    mutated proteins. The scheme also shows inhibitors and their targets—drugs approved
    in melanoma treatment are bolded, we also show other potential inhibitors (drugs
    in development or registered in other indications). RTK–receptor tyrosine kinase;
    RTKs–receptor tyrosine kinases; BRAF–proto-oncogene B-Raf; BRAFi–BRAF inhibitors;
    ARAF–serine/threonine-protein kinase A-Raf; CRAF–RAF proto-oncogene serine/threonine-protein
    kinase, also known as proto-oncogene c-RAF; PI3K–phosphoinositide 3-kinases; P–phosphoprotein;
    MEK–mitogen-activated protein kinase kinase; ERK–extracellular-signal-regulated
    kinase; COT–mitogen-activated protein kinase kinase kinase 8 or serine/threonine-protein
    kinase cot-1; MCL-1–induced myeloid leukemia cell differentiation protein Mcl-1;
    AKT–protein kinase B, also known as Akt; Rb–the retinoblastoma protein; Bad–BCL2
    associated agonist of cell death; c-Myc–Myc proto-oncogene protein; c-Jun–Jun-related
    antigen, isoform C; Ets–ETS transcription factor family; c-Fos–proto-oncogene
    c-Fos.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Tie
  - Ras85D
  - InR
  - ras
  - Ras64B
  - tx
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - mir-ban
  - Erk7
  - rl
  - Akt
  - CycE
  - cyc
  - kay
  - Ets21C
  - Ets65A
  - pnt
  - Ets96B
  - Ets97D
  - Ets98B
  - cass
  - Dronc
  - rb
  - Jra
  - KRAS
  - HRAS
  - NRAS
  - BRAF
  - ARAF
  - RAF1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAP3K8
  - CROT
  - EPHB2
  - MAPK1
  - MAPK3
  - AKT1
  - AKT2
  - AKT3
  - MCL1
  - FOS
  - ETS1
  - ETS2
  - BAD
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - JUN
  - Imatinib
  - Sunitinib
  - Vemurafenib
  - Dabrafenib
  - Encorafenib
  - Trametinib
  - Cobimetinib
  - Selumetinib
  - Binimetinib
  - Uprosertib
  - MK-2206
---
